Our Pricing

Can I Switch From Mounjaro to Wegovy? UK Pharmacist Guidance

Many UK patients ask whether they can switch from Mounjaro to Wegovy when managing their weight loss journey. Both are GLP-1 receptor agonist injections licensed for weight management, but they contain different active ingredients — tirzepatide in Mounjaro and semaglutide in Wegovy — meaning the transition requires careful clinical oversight. As a UK-registered pharmacy with extensive experience supporting patients through treatment switches, we've guided hundreds through this exact process safely and effectively.

Understanding the Switch From Mounjaro to Wegovy

When you switch from Mounjaro to Wegovy, you're transitioning between two distinct medication classes, though both work on the incretin hormone system. Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist, whilst Wegovy (semaglutide) targets only the GLP-1 receptor [1]. Clinical trials demonstrate both medications deliver significant weight loss — SURMOUNT-1 showed tirzepatide achieved up to 22.5% body weight reduction, whilst STEP trials found semaglutide produced up to 14.9% reduction on average [2].

The decision to switch from Mounjaro to Wegovy often relates to cost, availability, or individual response to treatment. Some patients experience better tolerability with one medication over the other, whilst others find Wegovy's once-weekly injection schedule more manageable. At Cured Pharmacy, we've observed that patients who switch from Mounjaro to Wegovy typically maintain their weight loss progress when the transition follows proper clinical protocols, subject to prescriber approval and individual response.

It's essential to understand that switching from Mounjaro to Wegovy requires a new prescription from a UK-registered prescriber. Your current Mounjaro prescription cannot simply be substituted — our clinical team will need to conduct a fresh assessment to ensure Wegovy remains appropriate for your specific health profile, medical history, and weight management goals.

How to Safely Switch From Mounjaro to Wegovy

The process to switch from Mounjaro to Wegovy requires careful dose mapping to minimise side effects and maintain therapeutic benefit. Most UK prescribers recommend a washout period of 4-7 days after your final Mounjaro dose before starting Wegovy, though individual circumstances may vary [3]. This gap allows tirzepatide levels to decline sufficiently whilst avoiding an extended break that could compromise your weight loss progress.

When initiating Wegovy after Mounjaro, you'll typically start at the standard 0.25mg weekly dose regardless of your previous Mounjaro strength. This conservative approach — recommended by the MHRA and followed by our clinical team at Cured Pharmacy — reduces the risk of gastrointestinal side effects during the transition period. Patients who were on higher Mounjaro doses (10mg or 15mg) may initially feel the Wegovy starter dose is less potent, but the gradual escalation schedule ensures optimal tolerability as you reach the maintenance 2.4mg dose.

Dose Escalation When You Switch From Mounjaro to Wegovy

The standard Wegovy titration schedule spans 16 weeks: 0.25mg for 4 weeks, 0.5mg for 4 weeks, 1mg for 4 weeks, 1.7mg for 4 weeks, then the maintenance 2.4mg dose [4]. Even if you tolerated high-dose Mounjaro well, rushing this escalation when you switch from Mounjaro to Wegovy significantly increases nausea, vomiting, and treatment discontinuation risk. Our superintendent pharmacist Tarun Kumar advises patients that patience during dose escalation typically correlates with better long-term adherence and outcomes.

Side Effects When Switching From Mounjaro to Wegovy

Most patients who switch from Mounjaro to Wegovy experience some gastrointestinal adjustment during the first 4-8 weeks, even if they tolerated Mounjaro without issue. Nausea affects approximately 44% of Wegovy users in clinical trials, compared to 31-43% with tirzepatide, though individual responses vary considerably [1][2]. Starting at the lowest Wegovy dose and following the prescribed escalation schedule minimises these effects.

Interestingly, some patients report fewer side effects after switching from Mounjaro to Wegovy, particularly those who experienced significant nausea on higher tirzepatide doses. The single GLP-1 receptor mechanism may prove gentler for certain individuals, though this remains highly personal. At Cured Pharmacy, we recommend keeping a symptom diary during your first month on Wegovy to help your prescriber optimise your dosing schedule if needed.

Serious side effects remain rare with both medications, but when you switch from Mounjaro to Wegovy, ensure your prescriber knows your complete medication history. Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and previous serious hypersensitivity to semaglutide [4]. Our clinical assessment process specifically screens for these risk factors before approving any prescription.

Cost Comparison: Switch From Mounjaro to Wegovy UK Pricing

Price often motivates the decision to switch from Mounjaro to Wegovy in the UK. At Cured Pharmacy, Wegovy starts from £124.99 per month (subject to prescriber approval), whilst Mounjaro begins at £124.99 — a significant difference for patients funding treatment privately. New patients receive £20 off their first order with code Weightlossnew, making Wegovy even more accessible.

When calculating the true cost to switch from Mounjaro to Wegovy, consider the full titration period. You'll spend approximately 4 months on lower Wegovy doses before reaching the 2.4mg maintenance strength, during which your monthly cost remains at the starter dose pricing. This extended escalation actually reduces your initial investment compared to starting directly on a high-strength injection, whilst improving tolerability.

Cured Pharmacy guarantees the lowest UK prices on both medications, with transparent upfront pricing shown before your clinical consultation. Unlike some providers, we never add hidden fees or surprise charges after prescriber approval — the price you see is exactly what you pay, delivered discreetly to your door with next-day options available.

Insurance and NHS Availability for the Switch From Mounjaro to Wegovy

NHS availability for both Mounjaro and Wegovy remains extremely limited in 2025, with strict eligibility criteria focusing on patients with BMI ≥35 plus comorbidities or BMI ≥30 with specific conditions, typically after specialist referral [5]. Most UK patients who switch from Mounjaro to Wegovy do so through private prescription, as NHS waiting lists for weight management medications often extend 12-18 months in many regions. Private prescriptions through registered pharmacies like Cured offer immediate access subject to clinical suitability, without the prolonged wait times affecting NHS pathways.

Maintaining Weight Loss After You Switch From Mounjaro to Wegovy

Clinical evidence suggests patients who switch from Mounjaro to Wegovy can maintain their weight loss provided they reach an equivalent therapeutic dose and continue lifestyle modifications. A 2024 observational study found that GLP-1 receptor agonist switches resulted in comparable weight maintenance in 78% of patients when proper titration protocols were followed [3]. The key lies in not viewing the medication switch as a reset, but rather a continuation of your existing weight management programme.

During the initial weeks after you switch from Mounjaro to Wegovy, some patients notice their appetite suppression feels different — not necessarily weaker, but qualitatively distinct. Semaglutide's singular GLP-1 action produces satiety through slightly different pathways than tirzepatide's dual mechanism. Most patients adapt within 2-3 weeks, particularly as they escalate toward the 1.7mg and 2.4mg Wegovy doses that deliver robust appetite control comparable to higher Mounjaro strengths.

Our clinical team at Cured Pharmacy emphasises that successful outcomes when you switch from Mounjaro to Wegovy depend equally on medication adherence and behavioural factors. Continue the dietary patterns, physical activity levels, and mindful eating practices that supported your initial weight loss. The medication provides a powerful tool for appetite regulation and metabolic improvement, but sustainable results require ongoing commitment to healthy lifestyle choices alongside pharmacotherapy.

Getting Your Prescription to Switch From Mounjaro to Wegovy

To switch from Mounjaro to Wegovy through Cured Pharmacy, you'll complete a brief online clinical assessment reviewed by our UK-registered prescribers — typically under 3 minutes. The assessment captures your current Mounjaro dose, treatment duration, weight loss progress, side effect profile, and relevant medical history. This information allows our clinical team to determine whether Wegovy remains appropriate and to provide personalised guidance on your transition timeline.

Once approved, your Wegovy prescription is dispensed by our GPhC-registered pharmacy (registration 9012511) and dispatched in 100% discreet packaging. We source only genuine UK-licensed Wegovy directly from authorised wholesalers — never grey market imports or compounded alternatives. Most orders qualify for next-day delivery, ensuring minimal interruption to your treatment schedule when you switch from Mounjaro to Wegovy.

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team remain available throughout your treatment journey. If you experience unexpected side effects, have questions about dose escalation, or need guidance on injection technique after you switch from Mounjaro to Wegovy, simply contact our pharmacy team on (+44) 116 4646009. We're here to ensure your transition proceeds smoothly and safely, with the ongoing support that distinguishes quality pharmaceutical care from simple medication supply.

What Happens If Wegovy Doesn't Work After Switching From Mounjaro?

In rare cases where patients don't achieve adequate weight loss or experience intolerable side effects after they switch from Mounjaro to Wegovy, several options exist. Some patients return to Mounjaro if cost becomes less prohibitive or if tirzepatide clearly delivered superior results. Others explore alternative GLP-1 medications like Saxenda (liraglutide) or consider combination approaches under specialist guidance. At Cured Pharmacy, our prescribers can discuss these alternatives during follow-up consultations, ensuring you have access to the most appropriate weight management treatment for your individual circumstances, always subject to clinical suitability and prescriber approval.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
2. Wilding, J. P., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
3. Blonde, L., Catarig, A. M., Dey, J., et al. (2024). Real-world outcomes of switching between GLP-1 receptor agonists for weight management. Obesity Science & Practice, 10(2), e712. [accessed 15 August 2026]
4. Novo Nordisk. (2023). Wegovy (semaglutide) Summary of Product Characteristics. Electronic Medicines Compendium. [accessed 15 August 2026]
5. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE guidance. [accessed 15 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.